Skip to content

Chronic Venous ULcer TReatment Analyzing Bio-Electrical Stimulation Therapy

Chronic Venous ULcer TReatment Analyzing Bio-Electrical Stimulation Therapy

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00678847
Enrollment
50
Registered
2008-05-16
Start date
2008-03-31
Completion date
2009-03-31
Last updated
2008-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Venous Leg Ulcers

Keywords

bio-electrical stimulation therapy, chronic venous ulcers, microcurrent, chronic wounds, complete healing

Brief summary

Indication: Subjects with chronic venous leg ulcers Primary Objective: • To evaluate the efficacy of bio-electrical stimulation therapy in the healing of chronic venous leg ulcers Secondary Objective(s): * To evaluate the percentage of wound healing every two weeks * To evaluate the complete ulcer healing every two weeks * To evaluate the time to complete ulcer healing * To evaluate the recurrence rate at the end of the follow-up period * To evaluate pain * To evaluate the quality of life Study Design and Treatment Scheme: This is a Kingfisher Healthcare NV sponsored, national, multicenter, randomized, prospective study in which data will be collected of subjects with chronic venous leg ulcers receiving standardized conventional therapy (SCT). Subjects will be randomized into two groups receiving SCT + placebo or SCT + bio-electrical stimulation therapy (BEST) to evaluate the effect of BEST on the wound healing process. Patients answering the eligibility criteria will receive standardized conventional therapy during 4 weeks before actual study start and will then again be evaluated on eligibility according to wound healing rate. Only patients with a wound surface that has not significantly changed (both increased or decreased) will be randomized in the treatment period. During the treatment period patients will receive SCT with placebo or SCT in combination with bio-electrical stimulation therapy on a daily basis for two hours, during 8 weeks. Patients will be in follow-up period for a maximum of 8 weeks after treatment period.

Detailed description

see above

Interventions

DEVICEKFH NOVO (inactive) + SCT

inactive device (placebo) 2 x 1hour/day for total period of 8 weeks + standardized conventional therapy (SCT)

DEVICEKFH Novo (BEST) + SCT

2 x 1 hour/day bio-electrical stimulation (BEST) for total period for total period of 8 weeks in combination with standardized conventional therapy (SCT)

Sponsors

Kingfisher Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult subjects ≥ 18 years old, male or female * Before any subject data is collected, the appropriate written informed consent must be obtained (see appendix H). * Confirmation of venous insufficiency during the last 5 years by Duplex examination * Chronic venous leg ulcers (\>12 weeks) not healing with conventional therapy * Study ulcer size between 8 to 20 cm² and without clinical signs of infection * No presence of other ulcers in a radius of 5 cm around the study ulcer * No surgery for venous insufficiency within the last 6 months * No arterial insufficiency (ABI between 0,7 and 1,3) * BMI \< 40 * No uncontrolled diabetes or any uncontrolled systemic condition that might impair wound healing * No decubitus wounds * Ambulant subject * Written informed consent

Exclusion criteria

* Subjects with implanted electrical devices (e.g. cardiac pacemakers) * Subjects having a concurrent malignancy or being less than 3 years after the end of their cancer therapy * Subjects with active osteomyelitis * Pregnant or breast-feeding women

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of bio-electrical stimulation therapy in the healing of chronic venous leg ulcersevery two weeks during treatment (8 weeks) and twice during follow-up period (8 weeks)

Secondary

MeasureTime frame
To evaluate painevery two weeks

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026